Perioperative Management of Oral Budesonide
For elective surgery, oral budesonide should be stopped preoperatively or dose-minimized wherever possible to reduce postoperative complications, though the evidence base specifically for budesonide timing is limited compared to systemic corticosteroids.
Key Recommendations
Preoperative Management
Stop or minimize budesonide before elective surgery when feasible to reduce risks of infectious complications, venous thromboembolism (VTE), and anastomotic leak 1.
The British Society of Gastroenterology 2025 guidelines emphasize that corticosteroids should be discontinued or brought to the lowest tolerable dose before non-emergency IBD surgery 1.
While these guidelines primarily address systemic corticosteroids like prednisolone, budesonide—despite having lower systemic bioavailability—still carries corticosteroid-related surgical risks 2.
Evidence-Specific to Budesonide
One retrospective study found preoperative budesonide was an independent predictor of early reoperation (OR = 6.77,95% CI = 0.98-46.48, p = 0.05) in Crohn's disease patients undergoing intestinal surgery 3.
This study specifically suggested that preoperative tapering of budesonide dose appears to be a safe option before elective abdominal surgery for Crohn's disease 3.
Perioperative Corticosteroid Coverage
If budesonide has been used for more than 4 weeks preoperatively, consider the potential for HPA axis suppression 2.
The FDA label warns that glucocorticosteroids, including budesonide, can reduce HPA axis response to stress, and supplementation with systemic glucocorticosteroid is recommended in situations where patients are subject to surgery 2.
For patients on systemic corticosteroids >4 weeks, intravenous hydrocortisone should be given perioperatively while nil by mouth 1.
Clinical Algorithm
For patients on oral budesonide planning elective surgery:
Assess disease activity and duration of budesonide use 1
- If disease is stable and surgery can be delayed, taper and discontinue budesonide preoperatively
- If disease requires ongoing control, reduce to minimum effective dose
For budesonide use >4 weeks, coordinate with anesthesia regarding potential need for perioperative stress-dose corticosteroids 2
- Anesthetists typically give a single steroid dose prior to induction (e.g., dexamethasone 4 mg IV/IM) for those on significant corticosteroid therapy 1
Monitor for increased infection risk perioperatively given immunosuppressive effects 2
Important Caveats
The specific timing for stopping budesonide is not explicitly defined in guidelines, unlike some other perioperative medications, requiring clinical judgment based on disease severity and surgical urgency 1.
Budesonide has lower systemic bioavailability than prednisolone (approximately 10-15%), but still carries corticosteroid-related risks including immunosuppression and impaired wound healing 2.
Emergency surgery considerations differ: these recommendations apply to elective procedures; emergency surgery in acute severe ulcerative colitis requires different management 1.
The association between budesonide and reoperation may reflect disease severity rather than direct drug effect, as patients requiring surgery despite medical therapy have more aggressive disease 3.